Unresectable Digestive System Neuroendocrine Neoplasm

Explore clinical trials studying Unresectable Digestive System Neuroendocrine Neoplasm. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Unresectable Digestive System Neuroendocrine Neoplasm trial results

Recruiting

Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.

NCT07150546

Conditions: Digestive System Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor, Unresectable Digestive System Neuroendocrine Neoplasm, +2 more
Locations: Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Hospital Atlanta, Georgia, United States

View Trial Details

Active, Not Recruiting

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

NCT03375320

Conditions: Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +42 more
Locations: Katmai Oncology Group Anchorage, Alaska, United States

Kingman Regional Medical Center Kingman, Arizona, United States

Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

View all 433 locations

View Trial Details

Unresectable Digestive System Neuroendocrine Neoplasm

Unresectable Digestive System Neuroendocrine Neoplasm trial results

Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

Related conditions